Back

Considering fatty liver disease as a novel risk factor for cardiovascular outcomes and mortality (cohort study)

6 April 2017 (15:30 - 16:30)
Organised by:
Congress Presentation Part of: Moderated Poster Session II - Epidemiology Epidemiology, lipids EAPC Premium Access EuroPrevent 2017

About the speaker

Photo
Professor Andrew Ryabikov

Novosibirsk State Medical University, Novosibirsk (Russian Federation)

7 More presentations in this session

Presentation thumbnail
Plasma choline and betaine and risk of incident atrial fibrillation: the Hordaland Health Study
Doctor H. Zuo (Bergen, NO)
Abstract
Presentation thumbnail
Incidence, treatment, mortality and further outcomes of acute myocardial infarction in the Czech Republic 1992-2012
Associate Professor O. Mayer (Pilsen, CZ)
Abstract
Presentation thumbnail
Trends in the risk of early and late-onset heart failure as an adverse outcome of acute myocardial infarction: a CVDNOR project
Doctor G. Sulo (Bergen, NO)
Abstract
Presentation thumbnail
Screening for total cholesterol in pharmacies is suitable to identify individuals with high cholesterol levels
Ms K. Svendsen (Oslo, NO)
Abstract
Presentation thumbnail
Ten-year changes in the prevalence of healthy lifestyle behaviors and factors among Polish Adults. Results of the National Multicenter Health Surveys WOBASZ (2003-2005) and WOBASZ II (2013-2014).

Access the full session

Session thumbnail
Moderated Poster Session II - Epidemiology

The Event

Event poster

EuroPrevent 2017

6 April 2017 15:30 CET
You may be interested in
thumbnail
Congress Presentation
Liver steatosis, metabolically healthy obesity and ten-year cardiovascular disease risk: results from a population based cohort study.
28 August 2021
thumbnail
ESC TV Today
Episode 26: Lp(a): the future starts now - Myocardial infarction in older age and frailty
6 November 2025
thumbnail
Congress Presentation
Liver fibrosis and poor outcome in patients with heart failure: new insights from the BIOSTAT-CHF study
31 August 2025
thumbnail
Congress Presentation
Adipose tissue and cardiac disease
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources